Effects of intravenous nifekalant, a class III antiarrhythmic drug, on atrial vulnerability parameters in patients with paroxysmal atrial fibrillation. [electronic resource]
Producer: 20040618Description: 212-7 p. digitalISSN:- 0147-8389
- Aged
- Aged, 80 and over
- Anti-Arrhythmia Agents -- administration & dosage
- Atrial Appendage -- drug effects
- Atrial Fibrillation -- drug therapy
- Atrial Function -- drug effects
- Bundle of His -- drug effects
- Coronary Vessels -- drug effects
- Electrocardiography -- drug effects
- Electrophysiology
- Female
- Heart Ventricles -- drug effects
- Humans
- Infusions, Intravenous
- Linear Models
- Male
- Matched-Pair Analysis
- Middle Aged
- Pyrimidinones -- administration & dosage
- Refractory Period, Electrophysiological -- drug effects
- Time Factors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.